Moleculin Biotech (MBRX) Insider Trading & Ownership $0.63 +0.08 (+14.54%) Closing price 04:00 PM EasternExtended Trading$0.63 +0.00 (+0.14%) As of 07:59 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Insider Trades Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock Moleculin Biotech (NASDAQ:MBRX) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage2.10%Number OfInsiders Buying(Last 12 Months)2Amount OfInsider Buying(Last 12 Months)$350.00KNumber OfInsiders Selling(Last 12 Months)0 Get MBRX Insider Trade Alerts Want to know when executives and insiders are buying or selling Moleculin Biotech stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address MBRX Insider Buying and Selling by Quarter Moleculin Biotech Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame Start Date End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails6/23/2025Jonathan P FosterCFOBuy270,270$0.37$99,999.90 6/23/2025Walter V KlempCEOBuy675,675$0.37$249,999.75 (Data available from 1/1/2013 forward) MBRX Insider Trading Activity - Frequently Asked Questions Who is on Moleculin Biotech's Insider Roster? The list of insiders at Moleculin Biotech includes Jonathan P Foster, Robert E George, and Walter V Klemp. Learn more on insiders at MBRX. What percentage of Moleculin Biotech stock is owned by insiders? 2.10% of Moleculin Biotech stock is owned by insiders. Learn more on MBRX's insider holdings. Which Moleculin Biotech insiders have been buying company stock? The following insiders have purchased MBRX shares in the last 24 months: Jonathan P Foster ($119,996.10), Robert E George ($9,998.10), and Walter V Klemp ($379,995.75). How much insider buying is happening at Moleculin Biotech? Insiders have purchased a total of 961,403 MBRX shares in the last 24 months for a total of $509,989.95 bought. Moleculin Biotech Key ExecutivesMr. Walter V. Klemp (Age 64)Founder, Chairman, President & CEO Compensation: $894.54k1 recent tradesMr. Jonathan P. Foster CPA (Age 60)Executive VP & CFO Compensation: $611.17k1 recent tradesDr. Donald H. Picker Ph.D. (Age 78)Chief Scientific Officer Compensation: $486.44kDr. Waldemar Priebe Ph.D.Co-Founder, Founding Scientist & Chairman of Scientific Advisory BoardDr. John Paul Waymack M.D. (Age 72)Sc.D., Senior Chief Medical Officer Dr. Sandra L. Silberman M.D. (Age 69)Ph.D., Chief Medical Officer of New Products Dr. Wolfram C. M. Dempke M.B.A.M.D., Ph.D., European Chief Medical OfficerMs. Jacqueline Northcut (Age 62)Consultant Compensation: $51.11kMr. Louis Ploth Jr. (Age 70)Independent Advisor Compensation: $118.49k More Insider Trading Tools from MarketBeat Related Companies Cingulate Insider Ownership Marker Therapeutics Insider Ownership BioVie Insider Ownership Q32 Bio Insider Ownership Mannatech Insider Ownership Reviva Pharmaceuticals Insider Ownership Lipocine Insider Ownership CASI Pharmaceuticals Insider Ownership Hoth Therapeutics Insider Ownership Lexaria Bioscience Insider Ownership Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles Insider Selling Hits Market Leaders—Should You Be Worried?3 Small Caps Drawing Insider and Institutional SupportDo They Know Something? Insiders & Congress Buy UnitedHealthMicron Insiders Sell But Investors Should Buy, Buy, BuySizzling Insider Buys for Your High-Yield Watchlist This page (NASDAQ:MBRX) was last updated on 7/14/2025 by MarketBeat.com Staff From Our PartnersMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredBanks aren’t ready for this altcoin—are you?Our expert analysts have identified a $100 billion gap in the crypto market. Only one project is perfectly ...Crypto 101 Media | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredHedge fund legend humiliates Bitcoin tradersLarry Benedict made $274 million trading on Wall Street… Barron’s ranked his hedge fund in the top 1% world...Brownstone Research | SponsoredTrump wipes out trillions overnight…Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out n...Porter & Company | SponsoredAn extra $1,000 per month?A little-known Title 15 provision could let you collect instant payouts — $100 to $1,000 — directly from your ...TradeSmith | SponsoredThis Social Security Shift Could Boost Benefits by 400%If you currently collect Social Security—or plan to in the future—this may be one of the most important update...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Moleculin Biotech, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Moleculin Biotech With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
